Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 85, Issue 2, 2009, Pages 189-196

  Ishiyama, Masami ^a   Suzuki, Eiji ^a,b   Katsuda, Jun ^a   Murase, Hiroshi ^a   Tajima, Yoshitaka ^a   Horikawa, Yukio ^a   Goto, Shinobu ^c   Fujita, Tamio ^c   Takeda, Jun ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

^c Nagoya Memorial Hospital   (Japan)

Author keywords

Bone related peptide; Carotid intima media thickness; Coronary artery calcification; Type 2 diabetes

Indexed keywords

OSTEOPONTIN; OSTEOPROTEGERIN;

ADULT; AGE; ARTERY CALCIFICATION; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE DURATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

ADULT; AGE OF ONSET; AGED; ATHEROSCLEROSIS; CALCINOSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OSTEOPONTIN; OSTEOPROTEGERIN; TOMOGRAPHY, X-RAY COMPUTED;

EID: 67649836838     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2009.04.023     Document Type: Article

References (45)

1. Kharlip J., Naglieri R., Mitchell B.D., Ryan K.A., and Donner T.W. Screening for silent coronary heart disease in type 2 diabetes: clinical application of American Diabetes Association guidelines. Diabetes Care 29 (2006) 692-694
2. Wexler L., Brundage B., Crouse J., Detrano R., Fuster V., Maddahi J., et al. Coronary artery calcification: pathophysiology, epidemiology, imaging methods, and clinical implications, a statement for hearth professionals from the American Heart Association. Writing Group. Circulation 94 (1996) 1175-1192
3. Rumberger J.A., Simons D.B., Fitzpatrick L.A., Sheedy P.F., and Schwartz R.S. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 92 (1995) 2157-2162
4. Horiguchi J., Yamamoto H., Akiyama Y., Murakawa K., Hirai N., and Ito K. Coronary artery calcium scoring using 16-MDCT and a retrospective ECG-gating reconstruction algorithm. Am. J. Roentgenol. 183 (2004) 103-108
5. Lachman A.S., Spray T.L., Kerwin D.M., Shugoll G.I., and Roberts W.C. Medial calcinosis of Mönckeberg. A review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. Am. J. Med. 63 (1977) 615-622
6. Hosoi M., Sato T., Yamagami K., Hasegawa T., Yamakita T., Miyamoto M., et al. Impact of diabetes on coronary stenosis and coronary artery calcification detected by electron-beam computed tomography in symptomatic patients. Diabetes Care 25 (2002) 696-701
7. Mitsuhashi N., Onuma T., Kubo S., Takayanagi N., Honda M., and Kawamori R. Coronary artery disease and carotid artery intima-media thickness in Japanese type 2 diabetic patients. Diabetes Care 25 (2002) 1308-1312
8. Schurgin S., Rich S., and Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care 24 (2001) 335-338
9. Golledge J., McCann M., Mangan S., Lam A., and Karan M. Osteoprotegerin and osteopontin are expressed at high concentrations within symptomatic carotid atherosclerosis. Stroke 35 (2004) 1636-1641
10. Fitzpatrick L.A., Severson A., Edwards W.D., and Ingram R.T. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J. Clin. Invest. 94 (1994) 1597-1604
11. O'Brien E.R., Garvin M.R., Stewart D.K., Hinohara T., Simpson J.B., Schwartz S.M., et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler. Thromb. 14 (1994) 1648-1656
12. Giachelli C.M., Speer M.Y., Li X., Rajachar R.M., and Yang H. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ. Res. 96 (2005) 717-722
13. Hofbauer L.C., Shui C., Riggs B.L., Dunstan C.R., Spelsberg T.C., O'Brien T., et al. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem. Biophys. Res. Commun. 280 (2001) 334-339
14. Collin-Osdoby P., Rothe L., Anderson F., Nelson M., Maloney W., and Osdoby P. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J. Biol. Chem. 276 (2001) 20659-20672
15. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Lüthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
16. Price P.A., June H.H., Buckley J.R., and Williamson M.K. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1610-1616
17. Ohmori R., Momiyama Y., Taniguchi H., Takahashi R., Kusuhara M., Nakamura H., et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 170 (2003) 333-337
18. Jono S., Ikari Y., Shioi A., Mori K., Miki T., Hara K., et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 106 (2002) 1192-1194
19. Minoretti P., Falcone C., Calcagnino M., Emanuele E., Buzzi M.P., Coen E., et al. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur. Heart J. 27 (2006) 802-807
20. Anand D.V., Lahiri A., Lim E., Hopkins D., and Corder R. The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects. J. Am. Coll. Cardiol. 47 (2006) 1850-1857
21. Avignon A., Sultan A., Piot C., Elaerts S., Cristol J.P., and Dupuy A.M. Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients. Diabetes Care 28 (2005) 2176-2180
22. Orchard T.J., and Strandness Jr. D.E. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association 18-20 September 1992, New Orleans, Louisiana. Diabetes Care 16 (1993) 1199-1209
23. Maahs D.M., Snell-Bergeon J.K., Kinney G.L., Wadwa R.P., Garg S., Ogden L.G., et al. ACE-I/ARB treatment in type 1 diabetes patients with albuminuria is associated with lower odds of progression of coronary artery calcification. J. Diabetes Complications 21 (2007) 273-279
24. Hosomi N., Mizushige K., Ohyama H., Takahashi T., Kitadai M., Hatanaka Y., et al. Angiotensin-converting enzyme inhibition with enalapril slows progressive intima-media thickening of the common carotid artery in patients with non-insulin-dependent diabetes mellitus. Stroke 32 (2001) 1539-1545
25. Achenbach S., Ropers D., Pohle K., Leber A., Thilo C., Knez A., et al. Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation 106 (2002) 1077-1082
26. Taylor A.J., Kent S.M., Flaherty P.J., Coyle L.C., Markwood T.T., and Vernalis M.N. ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atrovastatin and pravastatin on carotid intima medial thickness. Circulation 106 (2002) 2055-2060
27. Alberti K.G., and Zimmet P.Z. Definition, diagnosis and classification of dibetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15 (1998) 539-553
28. Yamashina A., Tomiyama H., Takeda K., Tsuda H., Arai T., Hirose K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens. Res. 25 (2002) 359-364
29. Boulton A.J., Vinik A.I., Arezzo J.C., Bril V., Feldman E.L., Freeman R., et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28 (2005) 956-962
30. American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 31 (2008) S12-S54
31. Imai E., Horio M., Nitta K., Yamagata K., Iseki K., Hara S., et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin. Exp. Nephrol. 11 (2007) 41-50
32. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39 Suppl. 1 (2002) S46-S64
33. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte Jr. M., and Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15 (1990) 827-832
34. Trion A., and van der Laarse A. Vascular smooth muscle cells and calcification in atherosclerosis. Am. Heart J. 147 (2004) 808-814
35. Kragel A.H., Reddy S.G., Wittes J.T., and Roberts W.C. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation 80 (1989) 1747-1756
36. Shemesh J., Apter S., Itzchak Y., and Motro M. Coronary calcification compared in patients with acute versus in those with chronic coronary events by using dual-sector spiral CT. Radiology 226 (2003) 483-488
37. Shioi A., Katagi M., Okuno Y., Mori K., Jono S., Koyama H., et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ. Res. 91 (2002) 9-16
38. Jovinge S., Hultgårdh-Nilsson A., Regnström J., and Nilsson J. Tumor necrosis factor-alpha activates smooth muscle cell migration in culture and is expressed in the balloon-injured rat aorta. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 490-497
39. Janowitz W.R., Agatston A.S., Kaplan G., and Viamonte Jr. M. Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. Am. J. Cardiol. 72 (1993) 247-254
40. Yamasaki Y., Kawamori R., Matsushima H., Nishizawa H., Kodama M., Kajimoto Y., et al. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging. Diabetes 43 (1994) 634-639
41. Megnien J.L., Simon A., Lemariey M., Plainfossé M.C., and Levenson J. Hypertension promotes coronary calcium deposit in asymptomatic men. Hypertension 27 (1996) 949-954
42. Puato M., Palatini P., Zanardo M., Dorigatti F., Tirrito C., et al. Increase in carotid intima-media thickness in grade 1 hypertensive subjects: white-coat versus sustained hypertension. Hypertension 51 (2008) 1300-1305
43. Yamasaki Y., Kodama M., Nishizawa H., Sakamoto K., Matsuhisa M., Kajimoto Y., et al. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 23 (2000) 1310-1315
44. Tanaka N., Momiyama Y., Ohmori R., Yonemura A., Ayaori M., et al. Effect of atorvastatin on plasma osteopontin levels in patients with hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 26 (2006) e129-130
45. Nellemann B., Gormsen L.C., Dollerup J., Schmitz O., Mogensen C.E., Rasmussen L.M., et al. Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria. Diabetes Care 30 (2007) 3122-3124